Metabolic plasticity in resting and thrombin activated platelets.
Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4395425?pdf=render |
id |
doaj-ab466e185cc64b3b8f68f2bb25048a1e |
---|---|
record_format |
Article |
spelling |
doaj-ab466e185cc64b3b8f68f2bb25048a1e2020-11-24T21:11:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012359710.1371/journal.pone.0123597Metabolic plasticity in resting and thrombin activated platelets.Saranya RaviBalu ChackoHirotaka SawadaPhilip A KramerMichelle S JohnsonGloria A BenavidesValerie O'DonnellMarisa B MarquesVictor M Darley-UsmarPlatelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.http://europepmc.org/articles/PMC4395425?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Saranya Ravi Balu Chacko Hirotaka Sawada Philip A Kramer Michelle S Johnson Gloria A Benavides Valerie O'Donnell Marisa B Marques Victor M Darley-Usmar |
spellingShingle |
Saranya Ravi Balu Chacko Hirotaka Sawada Philip A Kramer Michelle S Johnson Gloria A Benavides Valerie O'Donnell Marisa B Marques Victor M Darley-Usmar Metabolic plasticity in resting and thrombin activated platelets. PLoS ONE |
author_facet |
Saranya Ravi Balu Chacko Hirotaka Sawada Philip A Kramer Michelle S Johnson Gloria A Benavides Valerie O'Donnell Marisa B Marques Victor M Darley-Usmar |
author_sort |
Saranya Ravi |
title |
Metabolic plasticity in resting and thrombin activated platelets. |
title_short |
Metabolic plasticity in resting and thrombin activated platelets. |
title_full |
Metabolic plasticity in resting and thrombin activated platelets. |
title_fullStr |
Metabolic plasticity in resting and thrombin activated platelets. |
title_full_unstemmed |
Metabolic plasticity in resting and thrombin activated platelets. |
title_sort |
metabolic plasticity in resting and thrombin activated platelets. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand. |
url |
http://europepmc.org/articles/PMC4395425?pdf=render |
work_keys_str_mv |
AT saranyaravi metabolicplasticityinrestingandthrombinactivatedplatelets AT baluchacko metabolicplasticityinrestingandthrombinactivatedplatelets AT hirotakasawada metabolicplasticityinrestingandthrombinactivatedplatelets AT philipakramer metabolicplasticityinrestingandthrombinactivatedplatelets AT michellesjohnson metabolicplasticityinrestingandthrombinactivatedplatelets AT gloriaabenavides metabolicplasticityinrestingandthrombinactivatedplatelets AT valerieodonnell metabolicplasticityinrestingandthrombinactivatedplatelets AT marisabmarques metabolicplasticityinrestingandthrombinactivatedplatelets AT victormdarleyusmar metabolicplasticityinrestingandthrombinactivatedplatelets |
_version_ |
1716754720116178944 |